Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-02-28 Cumbo Alexander EVP, Chief Commercial Officer Grant or award +6,700 8,567
2020-02-28 Cumbo Alexander EVP, Chief Commercial Officer Grant or award · Stock option (right to buy) +37,500 37,500
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Exercise or conversion +2,727 $13.71 $37K 13,888
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Exercise or conversion +3,895 $13.71 $53K 17,783
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Exercise or conversion +26,084 $26.24 $684K 43,867
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Sale −32,706 $125.50 $4.1M 11,161
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Sale −9,294 $125.50 $1.2M 1,867
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Exercise or conversion · Stock option (right to buy) −2,727 1,123
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Exercise or conversion · Stock option (right to buy) −3,895 0
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Exercise or conversion · Stock option (right to buy) −26,084 20,881
2019-03-28 Cumbo Alexander EVP, Chief Commercial Officer Grant or award +4,876 13,326
2019-03-28 Cumbo Alexander EVP, Chief Commercial Officer Shares withheld for taxes −2,165 $118.68 $257K 11,161
2019-03-04 Cumbo Alexander EVP, Chief Commercial Officer Grant or award · Stock option (right to buy) +45,000 45,000
2019-02-28 Cumbo Alexander EVP, Chief Commercial Officer Returned to the company −3,375 8,450
2019-02-01 Cumbo Alexander SVP, Chief Commercial Officer Exercise or conversion +2,250 $13.90 $31K 25,016
2019-02-01 Cumbo Alexander SVP, Chief Commercial Officer Exercise or conversion +5,250 $26.24 $138K 30,266
2019-02-01 Cumbo Alexander SVP, Chief Commercial Officer Sale −15,000 $140.00 $2.1M 15,266
2019-02-01 Cumbo Alexander SVP, Chief Commercial Officer Exercise or conversion · Stock Option (right to buy) −2,250 0
2019-02-01 Cumbo Alexander SVP, Chief Commercial Officer Exercise or conversion · Stock Option (right to buy) −5,250 46,965
2018-08-08 Cumbo Alexander SVP, Chief Commercial Officer Shares withheld for taxes −6,000 $121.02 $726K 22,766

Page 1 of 3 · 45 trades